TFIPS
CCXI

Towarzystwo Funduszy Inwestycyjnych PZU SA’s ChemoCentryx, Inc. CCXI Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,500
Closed -$33.5K – 395
2021
Q2 		$33.5K Hold
2,500
– – 0.04% 191
2021
Q1 		$128K Buy
+2,500
New +$150K 0.19% 70

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's CCXI Position: Q3 2021 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA sold out of ChemoCentryx, Inc. (CCXI) in Q3 2021, closing a stake of 2,500 shares — an estimated $33.5K sold.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in CCXI in Q1 2021 and held it in 2 quarters. The position peaked at $128K in Q1 2021. 140 funds tracked by Wall St. Rank hold CCXI as of Q3 2021.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA reported no remaining ChemoCentryx, Inc. position as of Q3 2021 after selling out during the quarter.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA sold 2,500 ChemoCentryx, Inc. shares in Q3 2021, an estimated $33.5K.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in ChemoCentryx, Inc. in Q1 2021 and held it in 2 quarters.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's ChemoCentryx, Inc. position peaked at $128K in Q1 2021.
  • 140 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2021.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q3 2021, filed 14 Aug 2025.